Clinical Trials Logo

Clinical Trial Summary

The goal of this prospective study is to analyse the hormonal components in the blood of patients that were diagnosed with empty sella. Hereby we only take the hormones into consideration that are produced by the pituitary gland and/or are influenced by it due to positive/negative feedback. These are GH, ACTH, TSH, FSH, LH, PRL, oxytocine, ADH but also IGF-1, estradiol, testosteron, F4 and cortisol. The purpose is to see if abnormalities of the blook levels can be explained by the absence/shrinking of the pituitary gland. During this study, there will be a blood draw twice. The reason is to avoid wrong positive and negative results. Together with the second blood draw, there will be an insuline tolerance test in all patients. MRI will only be done if the last taken image is more than two years old or if the MRI was not taken with main focus on the pituitary gland.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04700020
Study type Interventional
Source Universitair Ziekenhuis Brussel
Contact
Status Active, not recruiting
Phase N/A
Start date October 14, 2019
Completion date May 2021